Small molecules targeting aberrant STAT3 activity: killing breast tumour cells and inducing an anti-tumour immune response.
Gunning, Patrick T
6 records totalling $3,667,304.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| Canadian Institutes of Health Research | $3,667,304 | 6 records |
Records
Extending life in refractory medulloblastoma patients with cancer stem cell killing small molecules
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
Developing STAT5 protein inhibitors for treatment of Leukemia
CANADA RESEARCH CHAIRHOLDER - Tier 2 / TITULAIRE DE CHAIRE DE RECHERCHE DU CANADA - Niveau 2
Silencing Stat3 signaling in multiple myeloma: identifying potent small molecule inhibitors of Stat3